Inflammation in chronic heart failure: what is familiar, what is unfamiliar?
Author:
Affiliation:
1. Department of Clinical and Molecular Medicine; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg; Göteborg Sweden
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Reference9 articles.
1. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches;Gullestad;Am J Cardiol,2005
2. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL);Mann;Circulation,2004
3. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH;Anker;Int J Cardiol,2002
4. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial;Chung;Circulation,2003
5. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial;Torre-Amione;Lancet,2008
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances on the Role of Gut Microbiota in the Development of Heart Failure by Mediating Immune Metabolism;Current Problems in Cardiology;2024-03
2. Role of monocytes and dendritic cells in cardiac reverse remodelling after cardiac resynchronization therapy;BMC Cardiovascular Disorders;2023-11-15
3. A Systematic Review and Meta-analysis of Randomized Placebo-controlled Trials 1 Year after Starting Sodium-glucose Transporter-2 Inhibitors in Heart Failure Patients with Reduced Ventricular Ejection Fraction;Open Access Macedonian Journal of Medical Sciences;2022-01-09
4. Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results;International Journal of Molecular Sciences;2021-12-02
5. Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy;International Journal of Molecular Sciences;2021-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3